ETV2 primes hematoendothelial gene enhancers prior to hematoendothelial fate commitment.
Steimle JD, Kim C, Rowton M, Nadadur RD, Wang Z, Stocker M, Hoffmann AD, Hanson E, Kweon J, Sinha T, Choi K, Black BL, Cunningham JM, Moskowitz IP, Ikegami K.
Steimle JD, et al. Among authors: ikegami k.
Cell Rep. 2023 Jun 27;42(6):112665. doi: 10.1016/j.celrep.2023.112665. Epub 2023 Jun 17.
Cell Rep. 2023.
PMID: 37330911
Free PMC article.